Literature DB >> 2554932

Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes.

P A Guerne1, R Terkeltaub, B Zuraw, M Lotz.   

Abstract

Crystal-related joint diseases are often associated with systemic inflammatory manifestations, including increased levels of acute-phase proteins, leukocytosis, and fever. Recently, interleukin-6 (IL-6) has been identified as a pluripotent mediator of inflammatory and immunologic responses and the major hepatocyte-stimulating factor. In this study, we demonstrated that monosodium urate (MSU) and calcium pyrophosphate dihydrate (CPPD) crystals, and to a lesser extent, hydroxyapatite crystals, increased IL-6 production by synoviocytes and monocytes in vitro. Immunoprecipitation experiments showed that MSU and CPPD crystals, but not hydroxyapatite crystals, were able to increase the release of newly synthesized IL-6. Crystal-induced IL-6 stimulated acute-phase protein synthesis, immunoglobulin production, and hybridoma cell proliferation, which was neutralized by a specific antibody to IL-6. High levels of IL-6 were found in synovial fluid from patients with gout and pseudogout. These results demonstrate that MSU and CPPD crystals can induce IL-6 production in synoviocytes and monocytes, and that synovial fluid from patients with gout and pseudogout contains high levels of IL-6. Crystal-induced IL-6 is likely to be an important mediator of inflammatory responses in acute gout and pseudogout.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554932     DOI: 10.1002/anr.1780321114

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  42 in total

Review 1.  The role of crystals in articular tissue degeneration.

Authors:  H S Cheung
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

2.  Lack of association between IL-6 gene polymorphisms and rheumatoid arthritis in Turkish population.

Authors:  A Arman; A Coker; O Sarioz; N Inanc; H Direskeneli
Journal:  Rheumatol Int       Date:  2011-07-22       Impact factor: 2.631

3.  Role of the leucine-rich repeat domain of cryopyrin/NALP3 in monosodium urate crystal-induced inflammation in mice.

Authors:  Hal M Hoffman; Peter Scott; James L Mueller; Amir Misaghi; Sean Stevens; George D Yancopoulos; Andrew Murphy; David M Valenzuela; Ru Liu-Bryan
Journal:  Arthritis Rheum       Date:  2010-07

Review 4.  Gout in solid organ transplantation: a challenging clinical problem.

Authors:  Lisa Stamp; Martin Searle; John O'Donnell; Peter Chapman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Sirt1 inhibits gouty arthritis via activating PPARγ.

Authors:  Juan Wang; Guangliang Chen; Liangjing Lu; Hejian Zou
Journal:  Clin Rheumatol       Date:  2019-07-31       Impact factor: 2.980

Review 6.  An old disease with new insights: Update on diagnosis and treatment of gout.

Authors:  Berivan Bitik; M Akif Öztürk
Journal:  Eur J Rheumatol       Date:  2014-06-01

7.  Activation of human fibroblast-like synoviocytes by uric acid crystals in rheumatoid arthritis.

Authors:  Da P Chen; Chun K Wong; Lai S Tam; Edmund K Li; Christopher W K Lam
Journal:  Cell Mol Immunol       Date:  2011-09-26       Impact factor: 11.530

8.  Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis.

Authors:  D C Hammell; L P Zhang; F Ma; S M Abshire; S L McIlwrath; A L Stinchcomb; K N Westlund
Journal:  Eur J Pain       Date:  2015-10-30       Impact factor: 3.931

9.  Phagocytosis of monosodium urate crystals by human synoviocytes induces inflammation.

Authors:  Yessica Zamudio-Cuevas; Javier Fernández-Torres; Gabriela Angélica Martínez-Nava; Karina Martínez-Flores; Adriana Ramírez Olvera; Daniel Medina-Luna; Alma Delia Hernández Pérez; Carlos Landa-Solís; Alberto López-Reyes
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-10

Review 10.  Beyond Joints: a Review of Ocular Abnormalities in Gout and Hyperuricemia.

Authors:  Yael Sharon; Naomi Schlesinger
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.